Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
Condition(s) studied
Investigational drug(s) / intervention(s)
Xenon: 50% xenon by inhalation, delivered by customized xenon delivery system, that includes a ventilator, for the 24h period of TH/TTM. The inhalation therapy is provided in combination with protocol-directed Post-Cardiac Arrest Care dictated by the 2015 guidelines from the American Heart Association and the European Resuscitation Council.
Study summary
XePOHCAS: Prospective, randomized, multicenter interventional trial in adult subjects with out-of-hospital cardiac arrest comparing treatment with standard-of-care post-cardiac arrest intensive care (which is targeted temperature management \[TTM\]) to xenon by inhalation plus standard-of-care post-cardiac arrest intensive care (including TTM).
Eligibility
Primary outcome measure(s)
- functional outcome: degree of functional independence measured using a modified Rankin Scale (mRS) — 30 days after the cardiac arrest
The degree of functional independence will be measured using a modified Rankin Scale (mRS)
Trial sites (10)
| Facility | City | Region | Status |
|---|---|---|---|
| Hartford Hospital | Hartford | Connecticut | |
| University of Florida | Gainesville | Florida | |
| Memorial Hospital at Gulfport | Gulfport | Mississippi | |
| University Nebraska Medical Center | Omaha | Nebraska | |
| University at Buffalo | Buffalo | New York | |
| Wexner Medical Center, Ohio State University | Columbus | Ohio | |
| Baptist Memorial Hospital, Baptist Clinical Research Institute | Memphis | Tennessee | |
| Houston Methodist Research Institute | Houston | Texas | |
| Aalborg University Hospital | Aalborg | Denmark | |
| University Hospital, Rigshospitalet, Blegdamsvej 9 | Copenhagen | Denmark |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03176186 on ClinicalTrials.gov ↗ ← All trials in the USA